Based on 3 analysts offering 12 month price targets for Oncocyte Corp
Min Forecast
$4.00+29.87%
Avg Forecast
$4.42+43.41%
Max Forecast
$5.00+62.34%
Should I buy or sell OCX stock?
Based on 3 analysts offering ratings for Oncocyte Corp.
Buy
Strong Buy
1 analysts 33.33%
Buy
1 analysts 33.33%
Hold
1 analysts 33.33%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although OCX's forecast from analysts indicates a "Buy", our proven Zen Rating quant model rates OCX as a "Hold". Stocks with a Zen Rating of Hold have had an average return of +7.53% per year. Learn More
Be the first to know when Wall Street analysts revise their OCX stock forecasts and price targets.
OCX stock forecasts by analyst
Analyst / Firm
Rating
Action
Price Target
Upside/Downside
Date
Analyst Color
locked
locked
$00.00
+00.00%
2025-04-08
locked
locked
$00.00
+00.00%
2025-03-28
locked
locked
$00.00
+00.00%
2025-03-26
1 of 1
Forecast return on equity
Is OCX forecast to generate an efficient return?
Forecast return on assets
Is OCX forecast to generate an efficient return on assets?
Is Oncocyte Stock a good buy in 2025, according to Wall Street analysts?
The consensus among 3 Wall Street analysts covering (NASDAQ: OCX) stock is to Buy OCX stock.
Out of 3 analysts, 1 (33.33%) are recommending OCX as a Strong Buy, 1 (33.33%) are recommending OCX as a Buy, 1 (33.33%) are recommending OCX as a Hold, 0 (0%) are recommending OCX as a Sell, and 0 (0%) are recommending OCX as a Strong Sell.
What is OCX's earnings growth forecast for 2025-2025?
(NASDAQ: OCX) Oncocyte's forecast annual earnings growth rate of N/A is not forecast to beat the US Diagnostics & Research industry's average forecast earnings growth rate of N/A, and while it is not forecast to beat the US market's average forecast earnings growth rate of N/A.
Oncocyte's earnings in 2025 is -$60,926,000.
In 2025, OCX is forecast to generate -$24,309,392 in earnings, with the lowest earnings forecast at -$24,309,392 and the highest earnings forecast at -$24,309,392.
What is OCX's forecast return on equity (ROE) for 2025-2025?
(NASDAQ: OCX) forecast ROE is N/A, which is considered weak.
What is OCX's Price Target?
According to 3 Wall Street analysts that have issued a 1 year OCX price target, the average OCX price target is $4.42, with the highest OCX stock price forecast at $5.00 and the lowest OCX stock price forecast at $4.00.
On average, Wall Street analysts predict that Oncocyte's share price could reach $4.42 by Apr 8, 2026. The average Oncocyte stock price prediction forecasts a potential upside of 43.41% from the current OCX share price of $3.08.
What is OCX's Earnings Per Share (EPS) forecast for 2025-2025?
(NASDAQ: OCX) Oncocyte's current Earnings Per Share (EPS) is -$4.66. In 2025, OCX's EPS is forecast to hit -$0.85 (min: -$0.85, max: -$0.85).
What is OCX's forecast return on assets (ROA) for 2025-2025?
(NASDAQ: OCX) forecast ROA is -69.3%, which is lower than the forecast US Diagnostics & Research industry average of 8.82%.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.